Literature DB >> 4213123

Generalized hypersensitivity reaction and visceral arteritis with fatal outcome during glibenclamide therapy.

B F Clarke, I W Campbell, D J Ewing, G W Beveridge, M K MacDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4213123     DOI： 10.2337/diab.23.9.739

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  7 in total

Review 1.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

2.  Intrahepatic cholestasis and cutaneous bullae associated with glibenclamide therapy.

Authors:  V Wongpaitoon; P R Mills; R I Russell; R S Patrick
Journal:  Postgrad Med J       Date:  1981-04       Impact factor: 2.401

3.  Favorable effects of glibenclamide in a patient exhibiting idiosyncratic hepatotoxic reactions to both chlorpropamide and tolbutamide.

Authors:  Z Rumboldt; B Bota
Journal:  Acta Diabetol Lat       Date:  1984 Oct-Dec

Review 4.  Comparative tolerability profiles of oral antidiabetic agents.

Authors:  A J Krentz; R E Ferner; C J Bailey
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

Review 5.  Granulomatous hepatitis associated with glyburide.

Authors:  D Saw; E Pitman; M Maung; P Savasatit; D Wasserman; C K Yeung
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

Review 6.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

7.  Gliclazide-induced acute hepatitis with hypersensitivity features.

Authors:  Shivakumar Chitturi; Vu Le; James Kench; Christopher Loh; Jacob George
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.487
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.